Elevance Health EVP Erin Wessling Reports 4,241 RSUs and Options on Form 3
Rhea-AI Filing Summary
Elevance Health director and EVP & Chief Legal Officer Erin M. Wessling filed an initial Form 3 disclosing direct beneficial ownership of 4,241 shares of common stock (restricted share units vesting 9/3/2025–3/3/2028) and two employee stock options covering 394 shares (exercise price $562.29) and 1,922 shares (exercise price $395.50). The filing notes a paper Form 3 was delivered 08/21/2025 because the reporting person's Form ID was pending.
Positive
- Transparent disclosure of direct beneficial ownership including RSUs and option grants
- Vesting schedules and exercise prices are clearly stated enabling timeline analysis
Negative
- Form ID pending caused a paper Form 3 delivery rather than an initial electronic filing
Insights
TL;DR: Routine initial ownership disclosure by a newly reported officer; no material governance concerns evident.
The Form 3 documents standard Section 16 reporting for an officer who is also a director. Holdings consist of restricted share units and time‑vesting options with multi‑year vest schedules, aligning management incentives with shareholder value over time. The paper filing due to a pending Form ID is procedural and explained in the remarks; it does not alter the disclosed ownership.
TL;DR: Ownership and option grants disclosed are modest relative to a large-cap issuer and are typical compensation instruments.
The reported 4,241 RSUs and options for 2,316 total option shares (394 + 1,922) reflect executive compensation structures rather than material capital positions. Exercise prices are stated, and vesting/exercisability timelines are explicit, enabling investors to model potential dilution timing. No sales, purchases, or other unusual transactions were reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents restricted share units which vest on varying dates between 9/3/2025 and 3/3/2028. The option represents a right to purchase a total of 394 shares, and is exercisable in three annual installments, with two installments of 131 shares each and one installment of 132 shares, beginning on 9/3/2025, which is the one-year anniversary of the option grant date. The option represents a right to purchase a total of 1,922 shares, and is exercisable in three annual installments, with one installment of 640 shares and two installments of 641 shares each, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.
